# | Title | Journal | Year | Citations |
---|
1 | Extended and Saturation Prostatic Biopsy in the Diagnosis and Characterisation of Prostate Cancer: A Critical Analysis of the Literature | European Urology | 2007 | 292 |
2 | Is Erectile Dysfunction the “Tip of the Iceberg” of a Systemic Vascular Disorder? | European Urology | 2003 | 287 |
3 | European Association of Urology Guidelines on Priapism | European Urology | 2014 | 254 |
4 | Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations | European Urology | 2009 | 247 |
5 | ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males | International Journal of Impotence Research | 2009 | 232 |
6 | Extraperitoneal Laparoscopic Radical Prostatectomy | European Urology | 2001 | 229 |
7 | Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations | Journal of Andrology | 2009 | 229 |
8 | 4–Year Follow–Up Results of a European Prospective Randomized Study on Neoadjuvant Hormonal Therapy prior to Radical Prostatectomy in T2–3N0M0 Prostate Cancer | European Urology | 2000 | 227 |
9 | Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial | Urology | 2002 | 215 |
10 | Erectile Dysfunction Is Associated with a High Prevalence of Hyperlipidemia and Coronary Heart Disease Risk | European Urology | 2003 | 194 |
11 | Investigation, Treatment and Monitoring of Late-Onset Hypogonadism in Males | European Urology | 2005 | 178 |
12 | Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations | Journal of Developmental and Physical Disabilities | 2005 | 174 |
13 | ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males | Aging Male | 2009 | 160 |
14 | Venous Leakage: Surgical Treatment of a Curable Cause of Impotence | Journal of Urology | 1985 | 159 |
15 | PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL | Urology | 1999 | 152 |
16 | Androgen Deprivation Therapy for the Treatment of Prostate Cancer: Consider Both Benefits and Risks | European Urology | 2009 | 139 |
17 | Investigation, treatment and monitoring of late‐onset hypogonadism in males | Journal of Developmental and Physical Disabilities | 2009 | 138 |
18 | Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer | British Journal of Urology | 1998 | 133 |
19 | Trans-Obturator Vaginal Tape (TOT) for Female Stress Incontinence: One Year Follow-Up in 120 Patients | European Urology | 2005 | 130 |
20 | Investigation, treatment and monitoring of late-onset hypogonadism in males | Aging Male | 2005 | 126 |
21 | Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, and EAU Recommendations | Journal of Andrology | 2006 | 122 |
22 | Transurethral Needle Ablation (TUNA): Safety, Feasibility, and Tolerance of a New Office Procedure for Treatment of Benign Prostatic Hyperplasia | European Urology | 1993 | 114 |
23 | A Long-Term, Multicenter, Double-Blind Study of an Escherichia Coli Extract (OM-89) in Female Patients with Recurrent Urinary Tract Infections | European Urology | 2005 | 112 |
24 | Repeat Prostate Biopsy: Who, How and When? | European Urology | 2002 | 109 |
25 | Cabanas approach: Is sentinel node biopsy reliable for staging penile carcinoma? | Urology | 1986 | 106 |
26 | Long-Term Evaluation of Transurethral Needle Ablation of the Prostate (TUNA) for Treatment of Symptomatic Benign Prostatic Hyperplasia: Clinical Outcome up to Five Years from Three Centers | European Urology | 2003 | 102 |
27 | Testosterone and Prostate Cancer: Revisiting Old Paradigms | European Urology | 2009 | 92 |
28 | Endoscopic Treatment of Vesicoureteral Reflux in Children | Journal of Urology | 1987 | 91 |
29 | The Burden of Testosterone Deficiency Syndrome in Adult Men: Economic and Quality-of-Life Impact | Journal of Sexual Medicine | 2007 | 90 |
30 | What Is the Optimal Regimen for BCG Intravesical Therapy? | European Urology | 2000 | 88 |
31 | Fundamental Concepts Regarding Testosterone Deficiency and Treatment | Mayo Clinic Proceedings | 2016 | 88 |
32 | Prostate Size and Risk of High-Grade, Advanced Prostate Cancer and Biochemical Progression after Radical Prostatectomy: A Search Database Study | European Urology | 2006 | 87 |
33 | Laparoscopic Partial Nephrectomy with “On-Demand” Clamping Reduces Warm Ischemia Time | European Urology | 2007 | 82 |
34 | ORIGINAL RESEARCH—ENDOCRINOLOGY: A Comparison of NCEP-ATPIII and IDF Metabolic Syndrome Definitions with Relation to Metabolic Syndrome-Associated Sexual Dysfunction | Journal of Sexual Medicine | 2007 | 81 |
35 | Venous Impotence: Pathophysiology, Diagnosis and Treatment | Journal of Urology | 1993 | 74 |
36 | Cavernous Oxygen Tension and Smooth Muscle Fibers: Relation and Function | Journal of Urology | 1995 | 72 |
37 | The Interpretation of Serum Prostate Specific Antigen in Men Receiving 5α-Reductase Inhibitors: A Review and Clinical Recommendations | Journal of Urology | 2006 | 71 |
38 | Evaluation of Male Sexual Function in Patients with Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH) Treated with a Phytotherapeutic Agent (Permixon®), Tamsulosin or Finasteride | European Urology | 2005 | 66 |
39 | What are the immunologically active components of Bacille Calmette-Guérin in therapy of superficial bladder cancer? | International Journal of Cancer | 2000 | 61 |
40 | Laparoscopic radical prostatectomy: the learning curve | Current Opinion in Urology | 2005 | 61 |
41 | Nutrition and prostate cancer: evidence or suspicion? | Urology | 2001 | 57 |
42 | A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy | World Journal of Urology | 2019 | 56 |
43 | Corporeal Veno-Occlusive Dysfunction: Predominantly Intracavernous Muscular Pathology | Journal of Urology | 1997 | 55 |
44 | Modified corporoplasty for penilecurvature: 10 years' experience | Urology | 1994 | 54 |
45 | Select Screening in a Specific High-Risk Population of Patients Suggests a Stage Migration Toward Detection of Non–Muscle-Invasive Bladder Cancer | European Urology | 2011 | 51 |
46 | Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guérin (BCG) in patients with superficial bladder cancer | Clinical and Experimental Immunology | 1997 | 50 |
47 | Computerized Measurement of Penile Elastic Fibres in Potent and Impotent Men | European Urology | 1994 | 49 |
48 | Long‐term analysis of oncological outcomes after laparoscopic radical cystectomy in Europe: results from a multicentre study by the European Association of Urology (EAU) section of Uro‐technology | BJU International | 2015 | 48 |
49 | Laparoscopic Live Donor Right Nephrectomy: A New Technique to Maximize the Length of the Renal Vein Using a Modified Endo GIA Stapler | European Urology | 2007 | 46 |
50 | Lower urinary tract symptoms/benign prostatic hyperplasia: minimizing morbidity caused by treatment | Urology | 2003 | 45 |